Xenon Pharmaceuticals (XENE) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.63), $0.01 worse than the analyst estimate of ($0.62).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- Citi opens downside watch on Kroger ahead of earnings
- Goldman Sachs sees refinery exemptions boosting DK cash flow
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
